Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles

Cisplatin is a first-line clinical agent used for treating solid tumors. Cisplatin damages the DNA of tumor cells and induces the production of high levels of reactive oxygen species to achieve tumor killing. Tumor cells have evolved several ways to tolerate this damage. Extracellular vesicles (EVs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, Liu, Qingqing, Zhao, Yuanxin, Fu, Jiaying, Su, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418773/
https://www.ncbi.nlm.nih.gov/pubmed/37569723
http://dx.doi.org/10.3390/ijms241512347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418773/
https://www.ncbi.nlm.nih.gov/pubmed/37569723
http://dx.doi.org/10.3390/ijms241512347

Ejemplares similares